@article {Dur{\'a}n-Olivencia2021.04.15.21255510, author = {Miguel A. Dur{\'a}n-Olivencia and Serafim Kalliadasis}, title = {More than a year after the onset of the CoVid-19 pandemic in the UK: lessons learned from a minimalistic model capturing essential features including social awareness and policy making}, elocation-id = {2021.04.15.21255510}, year = {2021}, doi = {10.1101/2021.04.15.21255510}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {The number of new daily SARS-CoV-2 infections experienced an abrupt increase during the last quarter of 2020 in almost every European country. The phenomenological explanation offered was a new mutation of the virus, first identified in the UK. We use publicly available data in combination with a time-delayed controlled SIR model, which captures the effects of preventive measures and concomitant social response on the spreading of the virus. The model, which has a unique transmission rate, enables us to reproduce the waves of infection occurred in the UK. This suggests that the new SARS-CoV-2 UK variant is as transmissible as previous strains. Our findings reveal that the sudden surge in cases was in fact related to the relaxation of preventive measures and social awareness. We also simulate the combined effects of restrictions and vaccination campaigns in 2021, demonstrating that lockdown policies are not fully effective to flatten the curve; fully effective mitigation can only be achieved via a vigorous vaccination campaign. As a matter of fact, incorporating recent data about vaccine efficacy, our simulations advocate that the UK might have overcome the worse of the CoVid-19 pandemic, provided that the vaccination campaign maintains a rate of approximately 140k jabs per day.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe acknowledge financial support from the Engineering and Physical Sciences Research Council of the UK via Platform Grant No. EP/L020564/1.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data for the analysis was collected from https://coronavirus.data.gov.uk/. Specifically, new cases: https://coronavirus.data.gov.uk/details/cases, and vaccinations: https://coronavirus.data.gov.uk/details/vaccinations. https://coronavirus.data.gov.uk/details/cases https://coronavirus.data.gov.uk/details/cases}, URL = {https://www.medrxiv.org/content/early/2021/04/16/2021.04.15.21255510}, eprint = {https://www.medrxiv.org/content/early/2021/04/16/2021.04.15.21255510.full.pdf}, journal = {medRxiv} }